Paper37141971
Anticandidal activity of nanocomposite based on nanochitosan, nanostarch and mycosynthesized copper oxide nanoparticles against multidrug-resistant Candida.
Saied M and 4 others. Int J Biol Macromol, 2023. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Anticandidal activity of nanocomposite based on nanochitosan, nanostarch and mycosynthesized copper oxide nanoparticles against multidrug-resistant Candida. Papers, record 37141971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37141971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anticandidal activity of nanocomposite based on nanochitosan, nanostarch and mycosynthesized copper oxide nanoparticles against multidrug-resistant Candida.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Candidiasis | Major topic |
| Nanocomposites | Major topic |
| Metal Nanoparticles | Major topic |
| Candida | |
| Antifungal Agents | |
| Copper | |
| Candida tropicalis | |
| Candida glabrata | |
| Oxides |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42525348 | Myco-synthesized silver nanoparticles from Aspergillus niger AH1 as multifunctional anti-Helicobacter pylori agents: Antibacterial, antibiofilm, anti-urease, and antibiotic-synergistic activities. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42525348 | PubMed |
| 41272144 | Innovative vaginal wash formulation with Chitosan nanoparticles targets microbial pathogens, ovarian cancer and inflammation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41272144 | PubMed |
| 40826077 | Green starch nanoparticles production in situ using α-amylase from a newly isolated Bacillus subtilis strain-MA6: statistical designs and characterizations. | Microb Cell Fact | 2025 | https://conductscience.org/library/papers/40826077 | PubMed |
| 40775400 | Beta cyclodextrin stabilized cupric oxide nanoparticles assisted thermal therapy for lung tumor and its effective in vitro anticancer activity. | Sci Rep | 2025 | https://conductscience.org/library/papers/40775400 | PubMed |
| 40579405 | Synthesis of Chitosan based nanoemulsions and their characterization and antifungal activity toward fungi causing mucormycosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40579405 | PubMed |
| 40478322 | Bioactive preservative nano-packaging films based on food wastes of orange peels and Shrimp for apple (Malus domestica var. Anna) fruit quality and storage. | Bioresour Bioprocess | 2025 | https://conductscience.org/library/papers/40478322 | PubMed |
| 40214715 | Chitosan-Based Schiff Base Compounds: Synthesis, Chemical Characterization and Antibacterial Properties. | J Fluoresc | 2025 | https://conductscience.org/library/papers/40214715 | PubMed |
| 39794801 | Response surface methodology and repeated-batch fermentation strategies for enhancing lipid production from marine oleaginous Candida parapsilosis Y19 using orange peel waste. | Microb Cell Fact | 2025 | https://conductscience.org/library/papers/39794801 | PubMed |
| 39763627 | An eco-friendly and cost-effective approach for the synthesis of a novel GA@CuO-ZnO nanocomposite: characterization, antimicrobial and anticancer activities. | RSC Adv | 2025 | https://conductscience.org/library/papers/39763627 | PubMed |
| 38644870 | A sustainable approach to prepare green synthesis of copper nanoparticles of Bauhinia variegata & Saussurea lappa: Unveiling in-vitro anti-obesity applications. | Heliyon | 2024 | https://conductscience.org/library/papers/38644870 | PubMed |
| 38533339 | Endophytic Aspergillus hiratsukae mediated biosynthesis of silver nanoparticles and their antimicrobial and photocatalytic activities. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38533339 | PubMed |
| 37649674 | A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases. | Saudi Pharm J | 2023 | https://conductscience.org/library/papers/37649674 | PubMed |
| 37454158 | Green nanocoating-based polysaccharides decorated with ZnONPs doped Egyptian kaolinite for antimicrobial coating paper. | Sci Rep | 2023 | https://conductscience.org/library/papers/37454158 | PubMed |
| 37374882 | Biosynthesis, Characterization, and Antifungal Activity of Novel Trimetallic Copper Oxide-Selenium-Zinc Oxide Nanoparticles against Some Mucorales Fungi. | Microorganisms | 2023 | https://conductscience.org/library/papers/37374882 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37141971
GET https://conductscience.org/api/papers/v1/37141971/authors